iShares
Compare
Buy

iShares Biotechnology ETFIBB

iSharesSectorsTechnology#26 of 264 by YTD

$221.13

+2.6% last session

+31.1% YTD

Data as of 11/4/20264:00 PM ET · End-of-day

0%+25%+50%+75%+100%S&P 500 +91.7%+97.1%Oct 30, 2023Nov 4, 20260%+25%+50%+75%+100%S&P 500 +91.7%+97.1%Oct 30, 2023Nov 4, 2026
Dividend-adjusted total return · S&P 500 uses VOO · Oct 30, 2023 – Nov 4, 2026IBBS&P 500 · VOO
@TheETFTracker·theetftracker.com
Returns1D1M3MYTD1Y3Y5YMAX
Total return+2.6%+8.9%+14.6%+31.1%+40.7%+97.1%+42.1%+750.5%
Peer average+0.8%−8.7%−4.9%+9.4%+6.0%+90.4%+35.2%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%—
AUM
$11.2B
Expense ratio
0.44%
Distribution yield
0.2%
NAV
$215.42
Volume
2.2M
Avg. volume 30D
1.8M
High today
$221.26
Low today
$214.04
Previous close
$215.47
52-week high
$222.29
52-week low
$154.62
Our risk indicator
4/5

IBB in One Breath

IBB Among Technology ETFs

YTD
#1GNOMGlobal X+54.5%$109M
#2PSCTInvesco+37.2%$475M
#3FBTFirst Trust+35.3%$3.1B
#4IBBiShares+31.1%$11.2B
#5IBBQInvesco+31.0%$120M
#6PBEInvesco+28.8%$435M
#7SPTESP Funds+28.1%$243M
#8SNSRGlobal X+27.0%$196M
#9IXNiShares+26.4%$8.8B
End-of-day Nov 5, 2026 · 54 Technology ETFs by YTD
@TheETFTracker·theetftracker.com

$10,000 in IBB

5Y
$10,000 in IBB became
$14,214
In the S&P 500 (VOO)
$18,115
$10K$15K$14,214 IBB$18,115 VOOlow $6,907Oct 2021Nov 2026
Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO
@TheETFTracker·theetftracker.com

What IBB Holds

Today
Biotechnology63.4%
VRTX 7.5 · REGN 6.6 · MRNA 5.7 · ARGX 3.4 · RVMD 2.6 · GMAB 2.1 · ONC 2.0
Drug Manufacturers - General19.8%
GILD 8.9 · AMGN 8.3 · BIIB 2.5 · GRFS
Medical - Diagnostics & Research9.2%
NTRA 3.6 · ILMN 2.5 · CRL 1.1 · MEDP 1.0 · GRAL · CDNA · VCYT
Medical - Instruments & Supplies0.7%
RGEN
Medical - Healthcare Information Services0.6%
TEM
Drug Manufacturers - Specialty & Generic0.5%
ALKS
Medical - Devices0.4%
BRKR
iShares IBB · share of the fund by industry · as of Nov 4, 2026
@TheETFTracker·theetftracker.com

Gilead’s Share of IBB

Today
8.9%

$89 of every $1,000 in IBB is Gilead

Gilead held by IBB
$996M
Most Gilead per dollar
BBH14.2%
IBBQ9.0%
IBB8.9%
PJP6.1%
iShares IBB · each square = $10 of $1,000 · as of Nov 4, 2026
@TheETFTracker·theetftracker.com

IBB’s Share of Technology ETFs

Today
3.1%

of the $366B in 58 Technology ETFs

IBB
IBB$11.2B3.1%
VGT$155B42.3%
XLK$115B31.5%
55 others$84.8B23.2%
Technology ETF AUM · Nov 5, 2026
@TheETFTracker·theetftracker.com

IBB Fee per $100 vs Peers

Today
$0.44a year
per $100
$44 a year on $10,000
XLK$0.08
FTEC$0.08
VGT$0.09
IYW$0.37
IXN$0.37
IBB$0.44
Expense ratio · Technology peers · Nov 5, 2026
@TheETFTracker·theetftracker.com

Inside IBB

243 holdings · as of Nov 4, 2026
IBB

iShares Biotechnology ETF

Today
#TickerCompanyWeight ▼
1GILDGilead Sciences8.86%
2AMGNAmgen8.31%
3VRTXVertex Pharmaceuticals7.55%
4REGNRegeneron Pharmaceuticals6.61%
5MRNAModerna5.72%
6NTRANatera3.58%
7ARGXArgenx SE3.43%
8RVMDRevolution Medicines2.56%
9BIIBBiogen2.50%
10ILMNIllumina2.46%
BiotechnologyDrug Manufacturers - GeneralMedical - DiagnosticsMedical - InstrumentsMedical - Healthcare Information ServicesDrug Manufacturers - SpecialtyMedical - DevicesOther
iShares IBB · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 66.8%
@TheETFTracker·theetftracker.com

How It Compares

IBB

iShares Biotechnology ETF’s Peers

YTD
Trend
VGTVanguardReadDesk0.09%+23.1%+16.7%$154.5B
XLKSPDRReadDesk0.08%+23.0%+17.5%$115.0B
IYWiSharesReadDesk0.37%+20.7%+15.5%$23.5B
FTECFidelityReadDesk0.08%+23.1%+16.7%$22.1B
IBBiSharesThis fundReadDesk0.44%+31.1%+40.7%$11.2B
IXNiSharesReadDesk0.37%+26.4%+20.3%$8.8B
Technology peers · YTD and past-year returns · as of Nov 5, 2026 · sorted by AUM
@TheETFTracker·theetftracker.com

VGT vs IBB

YTD
VGTVanguard · TechnologyIBBiShares · Technology
Year to date
IBB wins+8.1 pts
Past year
IBB wins+24.1 pts
Fee
VGT winslower fee
Yield
VGT wins+0.3 pts
AUM
VGT13.7× more
2–2level
Vanguard VGT and iShares IBB · year-to-date · as of Nov 5, 2026 · AUM not scored
@TheETFTracker·theetftracker.com

IBB vs VOO

YTD
IBB · iShares Biotechnology
+31.1%
VOO · S&P 500
+13.4%
Gap
17.8 pts
0%+10%+20%+30%+31.1% IBB+13.4% VOOJan 1Nov 50%+20%+31.1% IBB+13.4% VOOJan 1Nov 5
iShares IBB and Vanguard VOO · YTD total return · as of Nov 5, 2026
@TheETFTracker·theetftracker.com

IBB vs Its Peer Average

YTD
IBBAvsBPeer average
1D+2.6%+0.8%
1M+8.9%−8.7%
3M+14.6%−4.9%
YTD+31.1%+9.4%
1Y+40.7%+6.0%
3Y+97.1%+90.4%
5Y+42.1%+35.2%
7–0IBB wins
57 Technology peers · each row scaled to its leader
@TheETFTracker·theetftracker.com

The Details

IBB

Risk

1Y
4/5our risk indicator
CalmerBumpier
Volatility · 1Y22.83%
Deepest drop · 1Y−9.6%
Lowest point · 5Y−31.8%
52-week range
$154.62−0.5% from the high$222.29
iShares IBB · past-year price moves · as of Nov 5, 2026
@TheETFTracker·theetftracker.com
IBB

Payouts by Year

13Y
$0.0112per share, Sep 2026
$0.152014’15’16’17’18’19’20’21$0.41’22’23’24’25$0.162026
Distribution yield0.2%
PaidEvery quarter
Latest ex-date · paidSep 15 · Sep 18, 2026
12 payouts added up$1.22 a share
iShares IBB · distributions by ex-date · 2014–2026
@TheETFTracker·theetftracker.com
All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

Trading & Liquidity

Net asset value$215.42
Premium / discount[…]
Median spread · 30D[…]
Volume today2.2M
Average volume · 30D1.8M
Shares outstanding[…]
Options[…]

Fees & Costs

Net expense ratio0.44%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$44.00
Our risk indicator4/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-datePaidPer share
Sep 15, 2026Sep 18, 2026$0.0112
Jun 15, 2026Jun 18, 2026$0.0238
Mar 17, 2026Mar 20, 2026$0.12
Dec 16, 2025Dec 19, 2025$0.18
Sep 16, 2025Sep 19, 2025$0.0828
Mar 18, 2025Mar 21, 2025$0.12
Dec 17, 2024Dec 20, 2024$0.0624
Sep 25, 2024Sep 30, 2024$0.20
Mar 21, 2024Mar 27, 2024$0.13
Dec 20, 2023Dec 27, 2023$0.12
Sep 26, 2023Oct 2, 2023$0.15
Jun 7, 2023Jun 13, 2023$0.0062
Issuer contentFrom iSharesHear the strategy from the people behind IBB.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →